390 related articles for article (PubMed ID: 26233843)
1. Asiatic acid mitigates hyperglycemia and reduces islet fibrosis in Goto-Kakizaki rat, a spontaneous type 2 diabetic animal model.
Wang X; Lu Q; Yu DS; Chen YP; Shang J; Zhang LY; Sun HB; Liu J
Chin J Nat Med; 2015 Jul; 13(7):529-34. PubMed ID: 26233843
[TBL] [Abstract][Full Text] [Related]
2. Accelerated loss of islet beta cells in sucrose-fed Goto-Kakizaki rats, a genetic model of non-insulin-dependent diabetes mellitus.
Koyama M; Wada R; Sakuraba H; Mizukami H; Yagihashi S
Am J Pathol; 1998 Aug; 153(2):537-45. PubMed ID: 9708813
[TBL] [Abstract][Full Text] [Related]
3.
Zambrana S; Lundqvist LCE; Mamani O; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jul; 10(7):. PubMed ID: 30037028
[No Abstract] [Full Text] [Related]
4. Stevioside induces antihyperglycaemic, insulinotropic and glucagonostatic effects in vivo: studies in the diabetic Goto-Kakizaki (GK) rats.
Jeppesen PB; Gregersen S; Alstrup KK; Hermansen K
Phytomedicine; 2002 Jan; 9(1):9-14. PubMed ID: 11924770
[TBL] [Abstract][Full Text] [Related]
5. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
[TBL] [Abstract][Full Text] [Related]
6. Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats.
Höög A; Sandberg-Nordqvist AC; Abdel-Halim SM; Carlsson-Skwirut C; Guenifi A; Tally M; Ostenson CG; Falkmer S; Sara VR; Efendić S; Schalling M; Grimelius L
Endocrinology; 1996 Jun; 137(6):2415-23. PubMed ID: 8641194
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Glucose Tolerance and Pancreatic Beta Cell Function by Low Dose Aspirin in Hyperglycemic Insulin-Resistant Type 2 Diabetic Goto-Kakizaki (GK) Rats.
Amiri L; John A; Shafarin J; Adeghate E; Jayaprakash P; Yasin J; Howarth FC; Raza H
Cell Physiol Biochem; 2015; 36(5):1939-50. PubMed ID: 26202354
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with the Na+-glucose cotransporter inhibitor T-1095 causes sustained improvement in hyperglycemia and prevents diabetic neuropathy in Goto-Kakizaki Rats.
Ueta K; Ishihara T; Matsumoto Y; Oku A; Nawano M; Fujita T; Saito A; Arakawa K
Life Sci; 2005 Apr; 76(23):2655-68. PubMed ID: 15792833
[TBL] [Abstract][Full Text] [Related]
9. Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat.
Homo-Delarche F; Calderari S; Irminger JC; Gangnerau MN; Coulaud J; Rickenbach K; Dolz M; Halban P; Portha B; Serradas P
Diabetes; 2006 Jun; 55(6):1625-33. PubMed ID: 16731824
[TBL] [Abstract][Full Text] [Related]
10. Effects of Resveratrol in Goto-Kakizaki Rat, a Model of Type 2 Diabetes.
Szkudelska K; Deniziak M; Hertig I; Wojciechowicz T; Tyczewska M; Jaroszewska M; Szkudelski T
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623226
[TBL] [Abstract][Full Text] [Related]
11. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
[TBL] [Abstract][Full Text] [Related]
12. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
Movassat J; Saulnier C; Portha B
Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
[TBL] [Abstract][Full Text] [Related]
13. Two-week treatment with the β₃-adrenoceptor antagonist SR59230A normalizes the increased pancreatic islet blood flow in type 2 diabetic GK rats.
Pettersson US; Sandberg M; Jansson L
Diabetes Obes Metab; 2012 Oct; 14(10):960-2. PubMed ID: 22564532
[TBL] [Abstract][Full Text] [Related]
14. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
15. Expression of Protein Kinase C Isoforms in Pancreatic Islets and Liver of Male Goto-Kakizaki Rats, a Model of Type 2 Diabetes.
Seed Ahmed M; Pelletier J; Leumann H; Gu HF; Östenson CG
PLoS One; 2015; 10(9):e0135781. PubMed ID: 26398746
[TBL] [Abstract][Full Text] [Related]
16. Amaranthus caudatus Stimulates Insulin Secretion in Goto-Kakizaki Rats, a Model of Diabetes Mellitus Type 2.
Zambrana S; Lundqvist LCE; Veliz V; Catrina SB; Gonzales E; Östenson CG
Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342984
[TBL] [Abstract][Full Text] [Related]
17. Conophylline suppresses pancreatic stellate cells and improves islet fibrosis in Goto-Kakizaki rats.
Saito R; Yamada S; Yamamoto Y; Kodera T; Hara A; Tanaka Y; Kimura F; Takei I; Umezawa K; Kojima I
Endocrinology; 2012 Feb; 153(2):621-30. PubMed ID: 22202163
[TBL] [Abstract][Full Text] [Related]
18. Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4.
Tourrel C; Bailbe D; Lacorne M; Meile MJ; Kergoat M; Portha B
Diabetes; 2002 May; 51(5):1443-52. PubMed ID: 11978641
[TBL] [Abstract][Full Text] [Related]
19. Impaired beta-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes.
Plachot C; Movassat J; Portha B
Histochem Cell Biol; 2001 Aug; 116(2):131-9. PubMed ID: 11685541
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats.
Xu Z; Ju J; Wang K; Gu C; Feng Y
J Ethnopharmacol; 2014; 151(1):548-55. PubMed ID: 24269245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
